233.95
Penumbra Inc Aktie (PEN) Neueste Nachrichten
Is Penumbra Inc. a good long term investmentFree Stock Chart Pattern Guide - jammulinksnews.com
Penumbra Inc. Stock Analysis and ForecastPhenomenal returns - jammulinksnews.com
What analysts say about Penumbra Inc. stockExplosive capital gains - jammulinksnews.com
Penumbra (PEN) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance
Penumbra, Inc. Schedules Second Quarter 2025 Earnings Release and Conference Call for July 29, 2025 - Eastern Progress
What drives Penumbra Inc. stock priceBreakthrough profits - jammulinksnews.com
Penumbra, Inc.'s (NYSE:PEN) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? - simplywall.st
Penumbra's Strategic Growth Potential Bolstered by Upcoming Thunderbolt System Launch and Aspiration Technology Innovation - AInvest
Penumbra CEO's Stock Sale: A Routine Maneuver or Cause for Concern? - AInvest
Penumbra Insider Sold Shares Worth $3,896,344, According to a Recent SEC Filing - MarketScreener
Penumbra CEO Elsesser sells $3.89m in shares By Investing.com - Investing.com Nigeria
Penumbra CEO Elsesser sells $3.89m in shares - Investing.com Australia
NeoGenomics, RadNet, Pediatrix Medical Group, Penumbra, and Neogen Shares Plummet, What You Need To Know - Yahoo Finance
Penumbra (PEN) Announces Completion of Enrollment in STORM-PE Clinical Trial - Insider Monkey
Penumbra (PEN) Sees Price Target Reduction by Citi Ahead of Earnings | PEN Stock News - GuruFocus
Penumbra, Inc.'s (NYSE:PEN) P/S Still Appears To Be Reasonable - 富途牛牛
Insider Sell: Johanna Roberts Sells 600 Shares of Penumbra Inc (PEN) - GuruFocus
Penumbra EVP Roberts sells $151k in company stock By Investing.com - Investing.com Canada
Penumbra EVP Roberts sells $151k in company stock - Investing.com
Penumbra Inc EVP Sells 571 Shares for $144,143.47 on July 1, 2025. - AInvest
Penumbra CEO Adam Elsesser sells $4m in stock on June 25 - Investing.com Nigeria
Penumbra: AI Meets AspirationWhy The Stock Is A Structural Winner - Seeking Alpha
Thrombectomy Devices Market | Advancing Stroke Treatment & Clot - openPR.com
The Top 5 Analyst Questions From Penumbra’s Q1 Earnings Call - Yahoo Finance
Insider Selling: Bridget O'Rourke Sells Shares of Penumbra Inc (PEN) - GuruFocus
Penumbra director O’Rourke sells $12988 in stock - Investing.com
Inquis, Penumbra advance thrombectomy treatments - BioWorld MedTech
Transcript : Penumbra, Inc. Presents at 2025 Truist Securities MedTech Conference, Jun-17-2025 10 - MarketScreener
Penumbra, Inc. Announces Completion of Enrollment for Landmark S - GuruFocus
Penumbra Completes Enrollment for STORM-PE Randomized Controlled Trial - Diagnostic and Interventional Cardiology
Penumbra completes enrollment in pulmonary embolism trial - MassDevice
Penumbra's Revolutionary PE Treatment Trial Hits 100-Patient Mark, Results Could Transform Blood Clot Care - Stock Titan
Clot Management Devices Market Set to Witness Significant - openPR.com
PEN Stock Rises Following the Launch of Ruby XL System - MSN
RSI Alert: Penumbra (PEN) Now Oversold - Nasdaq
Zacks Industry Outlook Penumbra, Integer and AngioDynamics - Yahoo Finance
Penumbra Introduces the Ruby XL System – the Longest, Largest, and Softest Coil on the Market for Vascular Embolization - HMP Global Learning Network
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):